<DOC>
	<DOCNO>NCT01112397</DOCNO>
	<brief_summary>This study conduct assess safety , tolerability PK AZD1480 patient advance solid malignancy .</brief_summary>
	<brief_title>Study Assess Safety , Tolerability PK AZD1480 Patients With Solid Tumours</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Patients advance solid cancer without available therapy escalation phase mutation positive NSCLC nonsmoker primary tumor lung metastasis expansion phase ECOG Performance Status 01 Evidence postmenopausal status female male willing use barrier contraception Prior therapy JAK2 medication Significant lung disorder lung disease . Previous radiation therapy chest wall chest infection require antibiotic treatment within 21 day study screen . Evidence significant pulmonary hypertension COPD Eye disease cornea</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2013</verification_date>
	<keyword>Jak2</keyword>
	<keyword>cancer</keyword>
	<keyword>jak 1</keyword>
	<keyword>stat 3</keyword>
	<keyword>Phase 1</keyword>
</DOC>